Evidence map›Paper›PMID 17804249›Full record

ArticleNeurobiology of disease2007

Mouse models of diabetic neuropathy.

Kelli A Sullivan, John M Hayes, Timothy D Wiggin, Carey Backus, Sang Su Oh, Stephen I Lentz, Frank Brosius, Eva L Feldman

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 1 synthesis or guideline pooled it, 193 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Dietary folic acid prevents peripheral neuropathy in mouse models of neural tube defects and type 2 diabetes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Dietary interventions improve diabetic kidney disease, but not peripheral neuropathy, in a db/db mouse model of type 2 diabetes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kelli A SullivanDepartment of Neurology, University of Michigan, Ann Arbor, MI 48109-2200, USA.
John M Hayes
Timothy D Wiggin
Carey Backus
Sang Su Oh
Stephen I Lentz
Frank Brosius
Eva L Feldman
University of Michigan–Ann Arbor · US

Funding

PUBLIC HEALTH DEMONSTRATIONP60DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MYERS, MARTIN G · 1985 to 2012
$26.5M
Nation Center- Integrative Biomedical Informatics(RMI)U54DA021519 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ATHEY, BRIAN DAVID · 2005 to 2010
$21.3M
Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
Mouse Models of Diabetic Nephropathy and NeuropathyU01DK060994 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROSIUS, FRANK C · 2001 to 2005
$3.3M
GLUCOTOXICITY MEDIATES APOPTOSIS IN DIABETIC NEUROPATHYR01NS038849 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FELDMAN, EVA LUCILLE · 1998 to 2005
$854k
NIDA NIH HHS U54-DA021519NIDDK NIH HHS 5P60 DK20572NIDDK NIH HHS DK60994NIDDK NIH HHS P30 DK092926NIDDK NIH HHS P60 DK020572NIDDK NIH HHS U01 DK060994NINDS NIH HHS NS38849NINDS NIH HHS R01 NS038849
6 · The paper itself

Abstract

Diabetic neuropathy (DN) is a debilitating complication of type 1 and type 2 diabetes. Rodent models of DN do not fully replicate the pathology observed in human patients. We examined DN in streptozotocin (STZ)-induced [B6] and spontaneous type 1 diabetes [B6Ins2(Akita)] and spontaneous type 2 diabetes [B6-db/db, BKS-db/db]. Despite persistent hyperglycemia, the STZ-treated B6 and B6Ins2(Akita) mice were resistant to the development of DN. In contrast, DN developed in both type 2 diabetes models: the B6-db/db and BKS-db/db mice. The persistence of hyperglycemia and development of DN in the B6-db/db mice required an increased fat diet while the BKS-db/db mice developed severe DN and remained hyperglycemic on standard mouse chow. Our data support the hypothesis that genetic background and diet influence the development of DN and should be considered when developing new models of DN.

Indexed as

Disease Models, AnimalAnimalsDiabetic NeuropathiesDNA FragmentationHyperalgesiaIn Situ Nick-End LabelingMaleMiceMice, Inbred C57BLMice, Inbred DBAMice, Inbred NODNerve FibersNeural ConductionPain MeasurementReaction TimeStreptozocin3-nitrotyrosineStreptozocinTyrosineUbiquitin ThiolesteraseUchl1 protein, mouse

Identifiers

PMID17804249
PMCPMC3730836
OpenAlexW2011604885

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.